Answers are grounded in this paper and cite their sources.
Ageing is associated with progressively higher level of circulating pro-inflammatory markers without apparent cause [1]. The exact reason why such a pro-inflammatory condition emerges with ageing in most individuals is not known, but there is robust evidence that older persons with high inflammatory markers are at higher risk for developing many age-related medical conditions [2, 3], including poor physical performance and low muscle strength [4]. The role of inflammation as an independent risk factor for cardiovascular disease (CVD) is particularly interesting. Many CVD risk factors are well known including obesity, smoking and alcohol consumption [5]. Their association with CVD is so strong that those individuals who have low body fat and maintain a healthy lifestyle through diet, physical activity and abstinence from smoking have a 83% lower risk of CVD compared to the rest of the population [6]. Thus, finding another CVD risk factor that could be modulated by behavioral intervention is particularly important. The role of alcohol consumption as an independent risk factor for CVD has been extensively characterized. Using data from more than 26,000 women enrolled in the Women's Health Study, Djousse et al. [7] had shown that the relation between alcohol consumption and incident CVD and CVD mortality is J-shaped. In particular, those individuals who drank between 5 and 14.9 g of alcohol per day had significantly lower risk of CVD compared to those who abstained from alcohol or drank 15 g of alcohol per day or more. Furthermore, the hazard ratios of having high inflammatory /hemostatic factors such as high sensitivity C-reactive protein (CRP), soluble intracellular adhesion molecule-1 and fibrinogen were 21% lower in moderate alcohol users compared to abstainers or occasional drinkers and 13% lower when compared to heavy drinkers. Thus, it appeared that alcohol consumption had a bimodal effect on inflammation and the mechanism of this effect has never been understood. A possible hypothesis is that those individuals who are affected by clinical or subclinical diseases, such as diabetes, heart disease and/or hypertension, which are characterized by a pro-inflammatory state, avoid drinking alcohol, either spontaneously or because of suggestion by their physicians [8]. In accordance with this hypothesis, in the above-mentioned Women's Health Study, Djousse et al. postulated that health covariates such as hypertension or diabetes may have influenced subsequent consumption of alcohol. Some have referred to these individuals as so-called ‘sick quitters,’ similar to the loss of subjects in clinical trials who drop out of treatment for reasons related to the prognosis [7]. If sick quitters are compared to ‘moderate alcohol consumers’ who continue to drink because they are and feel healthy and to ‘heavy drinkers’, who drink amounts of alcohol that are overtly toxic, it understandable how the ‘j’- or ‘u’-shaped association curves of risk can be generated. Hence, the association of moderate alcohol use with low biomarkers of inflammation may not be biologically causative. Ergo, adding a few drinks to the diet would still be pleasurable, but perhaps not beneficial to health. However, if drinking a small glass of wine most days truly reduces the risk of developing CVD, perhaps by reducing inflammation, this effect should be reflected in public health recommendations. The study in the current issue of Age and Ageing by Shah and Paulson [9] adds clear evidence that a causal rather than behavioral association exists. In a very compelling mediation analysis, Shah and Paulson show that moderate alcohol consumption reduces the likelihood of frailty and that this preventive effect correlates with downregulation of CRP, an important biomarker of inflammation used in clinical practice. The study supports the premise that moderate alcohol benefits are real rather than being from a confounding or bias effect. Though the study does have limitations including that it is of a cross-sectional design, it does mechanistically add CRP to the conversation for the enduring health benefits of alcohol that have previously been shown when examining frailty risk [10, 11]. What is the mechanism by which moderate alcohol consumption reduces inflammation? One of the hypothesized mechanisms is that moderate alcohol consumption often implies the drinking of wine, which contains polyphenols such as resveratrol or flavonoids that have positive effects on metabolism. Also, these polyphenols have anti-inflammatory, antioxidant and antiplatelet activity, and randomized controlled trials have indicated that red wine consumption, in comparison to other alcoholic beverages, results in greater improvement to insulin sensitivity, lipid profiles and endothelial function [12]. Additionally, light to moderate ethanol levels may also directly reduce inflammation by increasing HDL cholesterol and adiponectin levels, and by improving insulin sensitivity and endothelial function [12]. Indeed, several US- and European-based studies have shown that people who report moderate alcohol intake tend to have lower CRP values [13–15]. In one diet-controlled cross-over study, moderate alcohol consumption was found to reduce CRP and fibrinogen levels [16]. With various studies including the one here by Shah and Paulson [9, 17, 18] showing a correlation between frailty and CRP levels, it is indeed not surprising that moderate alcohol consumption may in fact lead to lower CRP levels and hence frailty. It is significant that Shah and Paulson [9] showed this interaction in their pathway analyses described in their study. More research needs to be brought to fruition to fully understand the mechanisms by which moderate alcohol consumption is associated with reduced inflammation. Establishing such a relationship not only has important public health implications but may also help in understanding the mechanism for the pro-inflammatory state of ageing. Thus, it is important that more studies like the one by Shah and Paulson be performed on other inflammatory-related diseases of ageing where alcohol consumption may play a role. Unknown why inflammation increases with ageing Moderate alcohol use is associated with level of inflammation lower than not drinking or heavy drinking It is not clear whether those who do not drink are ‘sick quitters’ or whether moderate drinking is anti-inflammatory Important to show that causal pathways exist between drinking, level of biomarkers of inflammation and protective health effects More research needed to understand the mechanisms by which moderate alcohol consumption is associated with reduced inflammation None declared.
No takes yet. Share an insight, caveat, or question.
Bektas et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: